Type I Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Type I Diabetes stocks.

Type I Diabetes Stocks Recent News

Date Stock Title
May 3 NBIX Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024
May 2 ALKS Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
May 2 NBIX Neurocrine Biosciences First Quarter 2024 Earnings: EPS Misses Expectations
May 2 ALKS Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
May 2 NBIX Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
May 2 NBIX Q1 2024 Neurocrine Biosciences Inc Earnings Call
May 2 NBIX Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings: Strong Revenue Growth and Strategic Advancements
May 1 NBIX Neurocrine Q1 revenue beats Street, gets FDA okay for Ingrezza Sprinkle
May 1 NBIX Neurocrine Biosciences, Inc. (NBIX) Q1 2024 Earnings Call Transcript
May 1 NBIX Why Things Are Looking Up For IBD Stock Of The Day Neurocrine, A Top 1% Biotech
May 1 ALKS Alkermes plc (ALKS) Q1 2024 Earnings Call Transcript
May 1 ALKS Alkermes plc 2024 Q1 - Results - Earnings Call Presentation
May 1 ALKS Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
May 1 NBIX Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say
May 1 ALKS Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
May 1 NBIX Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
May 1 NBIX Neurocrine Biosciences Non-GAAP EPS of $1.20 misses by $0.09, revenue of $515.3M beats by $3.29M
May 1 ALKS Alkermes Non-GAAP EPS of $0.43 misses by $0.15, revenue of $350.4M misses by $9.87M
May 1 ALKS Alkermes plc Reports First Quarter 2024 Financial Results
May 1 NBIX Neurocrine Biosciences Reports First Quarter 2024 Financial Results
Type I Diabetes

Type 1 diabetes is an autoimmune disease in which the body's immune system attacks and destroys the cells in the pancreas that produce insulin. Without insulin, the body is unable to use glucose for energy, leading to high blood sugar levels and a range of serious health complications. People with type 1 diabetes must take insulin injections or use an insulin pump to manage their blood sugar levels.

Browse All Tags